Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China · Delayed Price · Currency is CNY 41.62
+0.02 (0.05%)
At close: Jan 23, 2026
SHA:603014 Market Cap
SHA:603014 has a market cap or net worth of 17.39 billion as of January 23, 2026.
Market Cap
17.39B
Enterprise Value
14.78B
Revenue
3.70B
Ranking
n/a
PE Ratio
34.52
Stock Price
41.62
Market Cap Chart
Since May 19, 2025, SHA:603014's market cap has increased from 17.04B to 17.39B, an increase of 2.06%. That is a compound annual growth rate of 3.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 17.38B | 4.97% |
| Dec 31, 2025 | 16.56B | -2.82% |
| May 19, 2025 | 17.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autobio Diagnostics | 21.08B |
| Double Medical Technology | 20.04B |
| MeHow Innovative | 18.32B |
| Jafron Biomedical | 15.50B |
| Beijing Balance Medical Technology | 15.40B |
| SonoScape Medical | 12.05B |
| Shanghai MicroPort EP MedTech | 12.02B |
| Shandong Weigao Orthopaedic Device | 11.91B |